Effectiveness, Implementation and Spillover Effects of a Culturally Adapted DPP in Spanish Primary Care Centers

ConditionPrediabetes
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of the Balearic Islands

About this trial

The ALADIM trial is a hybrid type II effectiveness-implementation cluster-randomized controlled, parallel, two arm, superiority trial. The clusters consist of 10 Primary Care Centers (PCCs) of Mallorca (Balearic Islands, Spain), which are randomly assigned to either the intervention or the control group in a 1:1 ratio. The intervention group (5 PCCs) receives training and supporting material to facilitate the implementation of the adapted DPP and effectively deliver the program over a 12-month period. The control group (5 PCCs) continues providing usual care, in line with standard healthcare practices. Effectiveness outcomes are assessed at participant level according to a cluster-randomized controlled design with data collection at baseline, 6-month and 12-month during the intervention period, and at 18-month follow-up to evaluate mid-term effects post-intervention. Implementation outcomes are assessed at PCC level throughout the study period. Prior to the hybrid trial, the DPP will be culturally and contextually adapted to the Spanish Primary Care setting.

The DPP will be culturally adapted using the Intervention Mapping ADAPT (IM-ADAPT) approach. Simultaneously, the implementation strategy will be designed using the Implementation Mapping approach.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Adapted Diabetes Prevention Program

    Behavioral

    Participants assigned to this group will participate in a group-based behavioural change program to improve diet and increase physical activity levels during 12 months.

  • Usual Care

    Behavioral

    Participants assigned to this groups will receive usual care according to national guidelines

Treatment groups

139 Participants
are divided into 2 treatment groups
Group A: Adapted Diabetes Prevention ProgramExperimental treatment 1 intervention
Group B: Usual careActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Weight

Change in body weight at 6 and 12 months versus baseline

Time frame
Baseline, 6 and 12 months
2

Implementation fidelity

Degree to which the adapted DPP is delivered as intended.

Time frame
Throughout the implementation period (from baseline to 12 months)

Secondary outcomes

1

Spill-over effect

Change in the percentage of individuals with prediabetes receiving lifestyle advice from their healthcare professional.

Time frame
-1, 6 and 18 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of the Balearic Islands

Lead sponsor

Instituto de Salud Carlos III

Collaborator

This trial is not recruiting at the moment. You can still explore other options: